{"date":"2026-03-01","count":6,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1799-2026-03-01-2254-svuqdj","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-03-01","time":"22:54:07","subject":"代子公司美國Tulex Pharmaceuticals公告,共同開發新藥(505(b)(2))液態口服治療尿崩症藥品,接獲美國FDA通知領取藥證","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-03-01 22:54，「代子公司美國Tulex Pharmaceuticals公告,共同開發新藥(505(b)(2))液態口服治療尿崩症藥品,接」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2026-03-01-1853-15ccmjv","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2026-03-01","time":"18:53:59","subject":"公告本公司114年度合併財務報告董事會預計召開日期為115年3月9日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2026-03-01 18:53，「公告本公司114年度合併財務報告董事會預計召開日期為115年3月9日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-03-01-1806-1yptoms","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-01","time":"18:06:21","subject":"公告本公司審計委員會及薪資報酬委員會委員逝世","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-03-01 18:06，「公告本公司審計委員會及薪資報酬委員會委員逝世」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-03-01-1805-t6mz3p","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-01","time":"18:05:42","subject":"公告本公司獨立董事逝世","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-03-01 18:05，「公告本公司獨立董事逝世」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4771-2026-03-01-1727-y130ph","company_id":"4771","company":"望隼","market":"上市","industry":"生技醫療","date":"2026-03-01","time":"17:27:20","subject":"公告本公司114年第4季財務報告董事會召開日期","clause":"第31款","fact_date":"2026-03-01","cite_as":"公開資訊觀測站重大訊息：望隼（4771），2026-03-01 17:27，「公告本公司114年第4季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2026-03-01-1306-zq2w4b","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2026-03-01","time":"13:06:29","subject":"本公司向新加坡衛生科學局 (HSA) 提交恩穩健腸病毒71型疫苗新藥審查 (NDA)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2026-03-01 13:06，「本公司向新加坡衛生科學局 (HSA) 提交恩穩健腸病毒71型疫苗新藥審查 (NDA)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}